UBS Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-51,534
| Closed | -$175K | – | 7455 |
|
|
2018
Q3 | $175K | Sell |
51,534
-11,030
| -18% | -$37.5K | ﹤0.01% | 4328 |
|
|
2018
Q2 | $235K | Sell |
62,564
-169,370
| -73% | -$636K | ﹤0.01% | 3994 |
|
|
2018
Q1 | $949K | Buy |
231,934
+129,296
| +126% | +$529K | ﹤0.01% | 3066 |
|
|
2017
Q4 | $477K | Sell |
102,638
-2,664
| -3% | -$12.4K | ﹤0.01% | 3496 |
|
|
2017
Q3 | $747K | Sell |
105,302
-82,848
| -44% | -$588K | ﹤0.01% | 3200 |
|
|
2017
Q2 | $1.36M | Sell |
188,150
-76,438
| -29% | -$553K | ﹤0.01% | 2693 |
|
|
2017
Q1 | $1.63M | Buy |
264,588
+28,416
| +12% | +$175K | ﹤0.01% | 2498 |
|
|
2016
Q4 | $1.38M | Sell |
236,172
-55,585
| -19% | -$326K | ﹤0.01% | 2575 |
|
|
2016
Q3 | $1.55M | Sell |
291,757
-56,387
| -16% | -$299K | ﹤0.01% | 2438 |
|
|
2016
Q2 | $2.31M | Sell |
348,144
-40,391
| -10% | -$267K | ﹤0.01% | 2085 |
|
|
2016
Q1 | $1.81M | Sell |
388,535
-75,870
| -16% | -$354K | ﹤0.01% | 2220 |
|
|
2015
Q4 | $2.35M | Sell |
464,405
-12,203
| -3% | -$61.6K | ﹤0.01% | 2067 |
|
|
2015
Q3 | $1.68M | Buy |
476,608
+226,629
| +91% | +$798K | ﹤0.01% | 2268 |
|
|
2015
Q2 | $2.5M | Sell |
249,979
-86,383
| -26% | -$862K | ﹤0.01% | 2139 |
|
|
2015
Q1 | $4.28M | Buy |
336,362
+165,539
| +97% | +$2.11M | ﹤0.01% | 1732 |
|
|
2014
Q4 | $2.42M | Buy |
+170,823
| New | +$2.42M | ﹤0.01% | 2094 |
|